CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- 4 Option exercise Director acquired 32,155 shares (option exercise)
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Acquisition or sale completed
- 8-K Event Other events
- 4 Option exercise Director acquired 30,000 shares (option exercise)
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 5,015 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 1,942 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,293 shares (to pay taxes)
Page 4 of 22 · 426 filings